Mural Oncology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Selling, General & Admin	30.71	17.73	15.55
Research & Development	165.53	167.19	159.82
Operating Expenses	196.24	184.92	175.37
Operating Income	-196.24	-184.92	-175.37
Other Expense / Income	-0.95	-	-
Pretax Income	-195.29	-184.92	-175.37
Income Tax	12.16	4.88	0.07
Net Income	-207.45	-189.81	-175.43
Shares Outstanding (Basic)	17	17	-
Shares Outstanding (Diluted)	17	17	-
EPS (Basic)	-12.43	-11.37	-
EPS (Diluted)	-12.43	-11.37	-
Free Cash Flow	-197.7	-174.1	-161.05
Free Cash Flow Per Share	-11.85	-10.43	-
EBITDA	-192.72	-183.38	-173.89
Depreciation & Amortization	2.57	1.54	1.47
EBIT	-195.29	-184.92	-175.37

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).